Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul;89(14):7425-7.
doi: 10.1128/JVI.00594-15. Epub 2015 May 6.

Interferon Gamma Prolongs Survival of Varicella-Zoster Virus-Infected Human Neurons In Vitro

Affiliations

Interferon Gamma Prolongs Survival of Varicella-Zoster Virus-Infected Human Neurons In Vitro

Nicholas L Baird et al. J Virol. 2015 Jul.

Abstract

Infection of human neurons in vitro with varicella-zoster virus (VZV) at a low multiplicity of infection does not result in a cytopathic effect (CPE) within 14 days postinfection (dpi), despite production of infectious virus. We showed that by 28 dpi a CPE ultimately developed in infected neurons and that interferon gamma inhibited not only the CPE but also VZV DNA accumulation, transcription, and virus production, thereby prolonging the life of VZV-infected neurons.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Inhibition of VZV spread in human neurons by IFN-γ. VZV-infected neurons were untreated (top) or treated with IFN-γ (bottom) for 14 dpi, fixed, and immunostained for an immediate early protein (VZV ORF63, green) and a late protein (VZV ORF68, red); 4′,6-diamidino-2-phenylindole staining is blue.
FIG 2
FIG 2
Prevention of VZV-induced CPE in human neurons by IFN-γ. At 28 dpi, CPE developed in VZV-infected neurons (top panel), characterized by rounding of cell bodies (dashed arrows) with retraction and fragmentation of neurites resembling a string of beads (solid arrows). VZV-infected neurons cultured in the presence of IFN-γ remained healthy at 28 dpi (bottom panel), exhibiting large cell bodies (dashed arrows) and extensive neurite outgrowth that forms a mesh throughout the culture (solid arrows).
FIG 3
FIG 3
Inhibition of VZV DNA accumulation and viral transcription in VZV-infected human neurons by IFN-γ. VZV-infected human neurons were either untreated (black bars) or treated with IFN-γ (gray bars) for 28 days, when the abundances of viral DNA (left) and transcripts (right) corresponding to VZV ORF62, ORF63, ORF29, and ORF68 were determined. Data are mean cycle threshold (CT) values ± standard deviations from 2 independent cultures.
FIG 4
FIG 4
Reduced production of infectious VZV in human neurons by IFN-γ. VZV-infected human neurons were either untreated (black bar) or IFN-γ treated (gray bar) for 28 days. At 28 dpi, when a CPE developed in untreated neurons, PFU were determined. Data are means ± standard deviations from 2 independent cultures.

References

    1. Gilden D, Mahalingam R, Nagel MA, Pugazhenthi S, Cohrs RJ. 2011. Review: the neurobiology of varicella zoster virus infection. Neuropathol Appl Neurobiol 37:441–463. doi:10.1111/j.1365-2990.2011.01167.x. - DOI - PMC - PubMed
    1. Nagel MA, Gilden D. 2013. Complications of varicella zoster virus reactivation. Curr Treat Options Neurol 15:439–453. doi:10.1007/s11940-013-0246-5. - DOI - PMC - PubMed
    1. Jenkins DE, Redman RL, Lam EM, Liu C, Lin I, Arvin AM. 1998. Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus. J Infect Dis 178:940–948. doi:10.1086/515702. - DOI - PubMed
    1. Torigoe S, Ihara T, Kamiya H. 2000. IL-12, IFN-gamma, and TNF-alpha released from mononuclear cells inhibit the spread of varicella-zoster virus at an early stage of varicella. Microbiol Immunol 44:1027–1031. doi:10.1111/j.1348-0421.2000.tb02599.x. - DOI - PubMed
    1. Haberthur K, Meyer C, Arnold N, Engelmann F, Jeske DR, Messaoudi I. 2014. Intrabronchial infection of rhesus macaques with simian varicella virus results in a robust immune response in the lungs. J Virol 88:12777–12792. doi:10.1128/JVI.01814-14. - DOI - PMC - PubMed

Publication types